Arkolith/Insider Trading/PBAX/Form 4

Geffken Daniel E.

Chief Financial OfficerPHOENIX BIOTECH ACQUISITION CORP. (PBAX) · full profile →Form 4 · filed Oct 12, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 8, 2021Other(J)30K——30K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-039940) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML